查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1598834

血管栓塞市场：按栓塞技术、应用和最终用户划分 - 全球预测 2025-2030

Vascular Embolization Market by Embolization Technique (Coiling Devices, Non-Coiling Devices), Application (Neurology, Oncology, Peripheral Vascular Disease), End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 193 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年血管栓塞市场价值为20.9亿美元，预计2024年将达到23.2亿美元，复合年增长率为11.38%，到2030年将达到44.5亿美元。

血管栓塞是一种微创医疗手术，用于故意阻塞血管以阻止血液流向特定区域。该手术对于治疗多种疾病至关重要，包括控制出血、治疗动脉瘤以及透过剥夺肿瘤的血液供应来治疗肿瘤。其应用涵盖多种医学专业，包括肿瘤学、神经学和创伤护理。最终用途范围主要包括医院、门诊手术中心以及能够进行先进诊断影像和导管插入术的专科诊所。影响血管栓塞市场成长的主要因素包括癌症和血管疾病盛行率的上升、微创技术的进步以及对专用栓塞设备的需求不断增加。世界人口老化也进一步增加了栓塞治疗的需求。新兴市场、不断上涨的医疗成本以及影像和微导管技术的技术进步带来了巨大的成长机会。此外，个人化医疗的日益普及也为市场进入者提供了开拓的潜力。然而，它面临着诸如栓塞技术和设备的高成本、熟练专家的有限性以及与非标靶栓塞等手术相关的潜在併发症挑战。严格的监管核准流程也阻碍了新产品的快速推出。创新机会在于开发生物分解性的栓塞剂、改进更精确的输送系统以及改进即时成像技术以提高手术的准确性和安全性。公司可以专注于投资研发、建立策略伙伴关係以利用先进技术，并扩展到新兴市场以实现成长。市场竞争激烈，技术进步迅速，持续创新和策略规划对于永续成长至关重要。

主要市场统计
基准年[2023] 20.9亿美元
预测年份 [2024] 23.2亿美元
预测年份 [2030] 44.5亿美元
复合年增长率（%） 11.38%

市场动态：揭示快速发展的血管栓塞市场的关键市场洞察

供需的动态交互作用正在改变血管栓塞市场。了解这些不断变化的市场动态可以帮助企业做出明智的投资决策、策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，并了解消费行为及其对製造成本的影响，并更清楚地了解对采购趋势的影响。

  • 市场驱动因素
    • 血管疾病盛行率增加
    • 人们越来越偏好微创治疗
    • 栓塞产品和程序的开发
  • 市场限制因素
    • 栓塞相关的高成本
  • 市场机会
    • 血管栓塞生物材料和技术的进展
  • 市场挑战
    • 与栓塞相关的併发症

波特五力：驾驭血管栓塞市场的策略工具

波特的五力框架是理解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解血管栓塞市场的外部影响

外部宏观环境因素在塑造血管栓塞市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析 了解血管栓塞市场的竞争状况

血管栓塞市场的详细市场占有率分析可以对供应商的绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵式血管栓塞市场供应商的绩效评估

FPNV 定位矩阵是评估血管栓塞市场供应商的关键工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议描绘了血管栓塞市场的成功之路

对于旨在加强在全球市场的影响力的公司来说，对血管栓塞市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：详细检视当前市场环境、主要企业的广泛资料、评估其在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 血管疾病盛行率增加
      • 人们对微创手术的兴趣日益浓厚
      • 栓塞产品和程序的开发
    • 抑制因素
      • 栓塞相关的高成本
    • 机会
      • 血管栓塞生医材料和技术的进展
    • 任务
      • 与栓塞相关的併发症
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章依栓塞技术分類的血管栓塞市场

  • 线圈装置
  • 非捲绕装置

第七章血管栓塞市场：依应用分类

  • 神经病学
  • 肿瘤学
  • 周围血管疾病
  • 泌尿系统

第八章血管栓塞市场：依最终用户分类

  • 门诊手术中心
  • 诊断中心
  • 医院
  • 专科诊所

第九章北美及南美血管栓塞市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十章亚太血管栓塞市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十一章欧洲、中东和非洲血管栓塞市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • Abbott Laboratories
  • B. Braun Melsungen AG
  • Becton, Dickinson and Company
  • Boston Scientific Corporation
  • Cook Medical Inc.
  • Kaneka Corporation
  • Lepu Medical Technology Co.,Ltd.
  • Medtronic PLC
  • Merit Medical Systems Inc.
  • Penumbra Inc
  • Shape Memory Medical Inc.
  • Stryker Corporation
  • Terumo Corporation
  • WL Gore & Associates Inc.
  • WEGO Healthcare Co., Ltd.
Product Code: MRR-742BD5184D4D

The Vascular Embolization Market was valued at USD 2.09 billion in 2023, expected to reach USD 2.32 billion in 2024, and is projected to grow at a CAGR of 11.38%, to USD 4.45 billion by 2030.

Vascular embolization is a minimally invasive medical procedure used to intentionally block a blood vessel to prevent blood flow to a specific area. This procedure is vital in treating a variety of medical conditions, including controlling bleeding, managing aneurysms, and treating tumors by starving them of their blood supply. Its application spans across various medical specialties such as oncology, neurology, and trauma care. The end-use scope primarily includes hospitals, ambulatory surgical centers, and specialized clinics where advanced imaging and catheterization equipment are available. Key factors influencing the growth of the vascular embolization market include the rising prevalence of cancer and vascular diseases, advancements in minimally invasive techniques, and increasing demand for specialized embolization devices. An aging global population further fuels the demand for these procedures. Emerging markets, increasing healthcare expenditure, and technological advancements in imaging and micro-catheter technology present substantial growth opportunities. Additionally, the increasing adoption of personalized medicine offers untapped potential for market players. However, the market faces challenges such as the high cost of embolization procedures and devices, limited availability of skilled professionals, and potential complications associated with the procedure, such as non-target embolization. Stringent regulatory approval processes can also hurdle the rapid introduction of new products. Innovation opportunities lie in the development of biodegradable embolic agents, enhancing delivery systems for better precision, and improving real-time imaging technologies to increase the accuracy and safety of procedures. Businesses can focus on investing in R&D, forming strategic partnerships to leverage advanced technologies, and expanding into emerging markets to capture growth. The market's nature is characterized by high competition and rapid technological advancements, making continuous innovation and strategic planning essential for sustained growth.

KEY MARKET STATISTICS
Base Year [2023] USD 2.09 billion
Estimated Year [2024] USD 2.32 billion
Forecast Year [2030] USD 4.45 billion
CAGR (%) 11.38%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Vascular Embolization Market

The Vascular Embolization Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing prevalence of vascular diseases
    • Increasing preference for minimally invasive procedures
    • Development in embolization products and procedures
  • Market Restraints
    • High costs associated with embolization procedures
  • Market Opportunities
    • Advances in biomaterials and technologies for vascular embolization
  • Market Challenges
    • Complications associated with embolization procedures

Porter's Five Forces: A Strategic Tool for Navigating the Vascular Embolization Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Vascular Embolization Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Vascular Embolization Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Vascular Embolization Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Vascular Embolization Market

A detailed market share analysis in the Vascular Embolization Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Vascular Embolization Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Vascular Embolization Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Vascular Embolization Market

A strategic analysis of the Vascular Embolization Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Vascular Embolization Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, B. Braun Melsungen AG, Becton, Dickinson and Company, Boston Scientific Corporation, Cook Medical Inc., Kaneka Corporation, Lepu Medical Technology Co.,Ltd., Medtronic PLC, Merit Medical Systems Inc., Penumbra Inc, Shape Memory Medical Inc., Stryker Corporation, Terumo Corporation, W. L. Gore & Associates Inc., and WEGO Healthcare Co., Ltd..

Market Segmentation & Coverage

This research report categorizes the Vascular Embolization Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Embolization Technique, market is studied across Coiling Devices and Non-Coiling Devices.
  • Based on Application, market is studied across Neurology, Oncology, Peripheral Vascular Disease, and Urology.
  • Based on End-User, market is studied across Ambulatory Surgical Centers, Diagnostics Centers, Hospitals, and Specialty Clinics.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing prevalence of vascular diseases
      • 5.1.1.2. Increasing preference for minimally invasive procedures
      • 5.1.1.3. Development in embolization products and procedures
    • 5.1.2. Restraints
      • 5.1.2.1. High costs associated with embolization procedures
    • 5.1.3. Opportunities
      • 5.1.3.1. Advances in biomaterials and technologies for vascular embolization
    • 5.1.4. Challenges
      • 5.1.4.1. Complications associated with embolization procedures
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Vascular Embolization Market, by Embolization Technique

  • 6.1. Introduction
  • 6.2. Coiling Devices
  • 6.3. Non-Coiling Devices

7. Vascular Embolization Market, by Application

  • 7.1. Introduction
  • 7.2. Neurology
  • 7.3. Oncology
  • 7.4. Peripheral Vascular Disease
  • 7.5. Urology

8. Vascular Embolization Market, by End-User

  • 8.1. Introduction
  • 8.2. Ambulatory Surgical Centers
  • 8.3. Diagnostics Centers
  • 8.4. Hospitals
  • 8.5. Specialty Clinics

9. Americas Vascular Embolization Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Vascular Embolization Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Vascular Embolization Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. B. Braun Melsungen AG
  • 3. Becton, Dickinson and Company
  • 4. Boston Scientific Corporation
  • 5. Cook Medical Inc.
  • 6. Kaneka Corporation
  • 7. Lepu Medical Technology Co.,Ltd.
  • 8. Medtronic PLC
  • 9. Merit Medical Systems Inc.
  • 10. Penumbra Inc
  • 11. Shape Memory Medical Inc.
  • 12. Stryker Corporation
  • 13. Terumo Corporation
  • 14. W. L. Gore & Associates Inc.
  • 15. WEGO Healthcare Co., Ltd.

LIST OF FIGURES

  • FIGURE 1. VASCULAR EMBOLIZATION MARKET RESEARCH PROCESS
  • FIGURE 2. VASCULAR EMBOLIZATION MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL VASCULAR EMBOLIZATION MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL VASCULAR EMBOLIZATION MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL VASCULAR EMBOLIZATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIZATION TECHNIQUE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIZATION TECHNIQUE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL VASCULAR EMBOLIZATION MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL VASCULAR EMBOLIZATION MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL VASCULAR EMBOLIZATION MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL VASCULAR EMBOLIZATION MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS VASCULAR EMBOLIZATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS VASCULAR EMBOLIZATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES VASCULAR EMBOLIZATION MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES VASCULAR EMBOLIZATION MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC VASCULAR EMBOLIZATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC VASCULAR EMBOLIZATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA VASCULAR EMBOLIZATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA VASCULAR EMBOLIZATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. VASCULAR EMBOLIZATION MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. VASCULAR EMBOLIZATION MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. VASCULAR EMBOLIZATION MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL VASCULAR EMBOLIZATION MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL VASCULAR EMBOLIZATION MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL VASCULAR EMBOLIZATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. VASCULAR EMBOLIZATION MARKET DYNAMICS
  • TABLE 7. GLOBAL VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIZATION TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL VASCULAR EMBOLIZATION MARKET SIZE, BY COILING DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL VASCULAR EMBOLIZATION MARKET SIZE, BY NON-COILING DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL VASCULAR EMBOLIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL VASCULAR EMBOLIZATION MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL VASCULAR EMBOLIZATION MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL VASCULAR EMBOLIZATION MARKET SIZE, BY PERIPHERAL VASCULAR DISEASE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL VASCULAR EMBOLIZATION MARKET SIZE, BY UROLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL VASCULAR EMBOLIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL VASCULAR EMBOLIZATION MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL VASCULAR EMBOLIZATION MARKET SIZE, BY DIAGNOSTICS CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL VASCULAR EMBOLIZATION MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL VASCULAR EMBOLIZATION MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIZATION TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS VASCULAR EMBOLIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS VASCULAR EMBOLIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS VASCULAR EMBOLIZATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 24. ARGENTINA VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIZATION TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 25. ARGENTINA VASCULAR EMBOLIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 26. ARGENTINA VASCULAR EMBOLIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 27. BRAZIL VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIZATION TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 28. BRAZIL VASCULAR EMBOLIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 29. BRAZIL VASCULAR EMBOLIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 30. CANADA VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIZATION TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 31. CANADA VASCULAR EMBOLIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 32. CANADA VASCULAR EMBOLIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 33. MEXICO VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIZATION TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 34. MEXICO VASCULAR EMBOLIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 35. MEXICO VASCULAR EMBOLIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 36. UNITED STATES VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIZATION TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 37. UNITED STATES VASCULAR EMBOLIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 38. UNITED STATES VASCULAR EMBOLIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 39. UNITED STATES VASCULAR EMBOLIZATION MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 40. ASIA-PACIFIC VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIZATION TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 41. ASIA-PACIFIC VASCULAR EMBOLIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 42. ASIA-PACIFIC VASCULAR EMBOLIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 43. ASIA-PACIFIC VASCULAR EMBOLIZATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 44. AUSTRALIA VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIZATION TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 45. AUSTRALIA VASCULAR EMBOLIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 46. AUSTRALIA VASCULAR EMBOLIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 47. CHINA VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIZATION TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 48. CHINA VASCULAR EMBOLIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 49. CHINA VASCULAR EMBOLIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 50. INDIA VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIZATION TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 51. INDIA VASCULAR EMBOLIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 52. INDIA VASCULAR EMBOLIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 53. INDONESIA VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIZATION TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 54. INDONESIA VASCULAR EMBOLIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 55. INDONESIA VASCULAR EMBOLIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 56. JAPAN VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIZATION TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 57. JAPAN VASCULAR EMBOLIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 58. JAPAN VASCULAR EMBOLIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 59. MALAYSIA VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIZATION TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 60. MALAYSIA VASCULAR EMBOLIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 61. MALAYSIA VASCULAR EMBOLIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 62. PHILIPPINES VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIZATION TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 63. PHILIPPINES VASCULAR EMBOLIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 64. PHILIPPINES VASCULAR EMBOLIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 65. SINGAPORE VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIZATION TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 66. SINGAPORE VASCULAR EMBOLIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 67. SINGAPORE VASCULAR EMBOLIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 68. SOUTH KOREA VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIZATION TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 69. SOUTH KOREA VASCULAR EMBOLIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 70. SOUTH KOREA VASCULAR EMBOLIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 71. TAIWAN VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIZATION TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 72. TAIWAN VASCULAR EMBOLIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 73. TAIWAN VASCULAR EMBOLIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 74. THAILAND VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIZATION TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 75. THAILAND VASCULAR EMBOLIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 76. THAILAND VASCULAR EMBOLIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 77. VIETNAM VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIZATION TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 78. VIETNAM VASCULAR EMBOLIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 79. VIETNAM VASCULAR EMBOLIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIZATION TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA VASCULAR EMBOLIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 82. EUROPE, MIDDLE EAST & AFRICA VASCULAR EMBOLIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 83. EUROPE, MIDDLE EAST & AFRICA VASCULAR EMBOLIZATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 84. DENMARK VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIZATION TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 85. DENMARK VASCULAR EMBOLIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 86. DENMARK VASCULAR EMBOLIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 87. EGYPT VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIZATION TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 88. EGYPT VASCULAR EMBOLIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 89. EGYPT VASCULAR EMBOLIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 90. FINLAND VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIZATION TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 91. FINLAND VASCULAR EMBOLIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 92. FINLAND VASCULAR EMBOLIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 93. FRANCE VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIZATION TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 94. FRANCE VASCULAR EMBOLIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 95. FRANCE VASCULAR EMBOLIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 96. GERMANY VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIZATION TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 97. GERMANY VASCULAR EMBOLIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 98. GERMANY VASCULAR EMBOLIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 99. ISRAEL VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIZATION TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 100. ISRAEL VASCULAR EMBOLIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 101. ISRAEL VASCULAR EMBOLIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 102. ITALY VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIZATION TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 103. ITALY VASCULAR EMBOLIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 104. ITALY VASCULAR EMBOLIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 105. NETHERLANDS VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIZATION TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 106. NETHERLANDS VASCULAR EMBOLIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 107. NETHERLANDS VASCULAR EMBOLIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 108. NIGERIA VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIZATION TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 109. NIGERIA VASCULAR EMBOLIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 110. NIGERIA VASCULAR EMBOLIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 111. NORWAY VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIZATION TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 112. NORWAY VASCULAR EMBOLIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 113. NORWAY VASCULAR EMBOLIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 114. POLAND VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIZATION TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 115. POLAND VASCULAR EMBOLIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 116. POLAND VASCULAR EMBOLIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 117. QATAR VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIZATION TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 118. QATAR VASCULAR EMBOLIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 119. QATAR VASCULAR EMBOLIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 120. RUSSIA VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIZATION TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 121. RUSSIA VASCULAR EMBOLIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 122. RUSSIA VASCULAR EMBOLIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 123. SAUDI ARABIA VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIZATION TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 124. SAUDI ARABIA VASCULAR EMBOLIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 125. SAUDI ARABIA VASCULAR EMBOLIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 126. SOUTH AFRICA VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIZATION TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 127. SOUTH AFRICA VASCULAR EMBOLIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 128. SOUTH AFRICA VASCULAR EMBOLIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 129. SPAIN VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIZATION TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 130. SPAIN VASCULAR EMBOLIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 131. SPAIN VASCULAR EMBOLIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 132. SWEDEN VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIZATION TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 133. SWEDEN VASCULAR EMBOLIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 134. SWEDEN VASCULAR EMBOLIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 135. SWITZERLAND VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIZATION TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 136. SWITZERLAND VASCULAR EMBOLIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 137. SWITZERLAND VASCULAR EMBOLIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 138. TURKEY VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIZATION TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 139. TURKEY VASCULAR EMBOLIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 140. TURKEY VASCULAR EMBOLIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED ARAB EMIRATES VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIZATION TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED ARAB EMIRATES VASCULAR EMBOLIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED ARAB EMIRATES VASCULAR EMBOLIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED KINGDOM VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIZATION TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 145. UNITED KINGDOM VASCULAR EMBOLIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 146. UNITED KINGDOM VASCULAR EMBOLIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 147. VASCULAR EMBOLIZATION MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 148. VASCULAR EMBOLIZATION MARKET, FPNV POSITIONING MATRIX, 2023